SLEEP DURATION: MODERN VIEW OF THE PROBLEM FROM THE STANDPOINT OF A CARDIOLOGIST
https://doi.org/10.20996/1819-6446-2015-11-4-413-419
Abstract
Today the role of disturbances in sleep duration in the development of various chronic diseases, including cardiovascular diseases is known and proven. In addition, the results of many clinical studies demonstrate the relationship between impaired sleep duration and the rate of telomere shortening. In turn, short telomeres are associated with the development of arterial hypertension, chronic heart failure, atherosclerosis and other diseases with high mortality both in Russia and worldwide. This article presents an overview of the clinical studies demonstrating the negative effect of sleep duration disturbances on total and cardiovascular mortality, as well as works that specify in detail the relation between sleep duration and telomere length.
About the Authors
O. M. Drapkina
I. M. Sechenov First Moscow State Medical University
Russian Federation
Trubetskaya ul. 8-2, Moscow, 119991 Russia
Russian Federation
Trubetskaya ul. 8-2, Moscow, 119991 Russia
R. N. Shepel'
I. M. Sechenov First Moscow State Medical University
Russian Federation
Trubetskaya ul. 8-2, Moscow, 119991 Russia
Russian Federation
Trubetskaya ul. 8-2, Moscow, 119991 Russia
References
1. Kovalzon V.M. About functions of sleep. Zhurnal evolyutsionnoy biokhimii i fiziologii 1993; 29 (5-6): 627-34. Russian (Ковальзон В.М. О функциях сна. Журнал эволюционной биохимии и физио-логии 1993; 29(5-6):627-634).
2. Romanov A.I., ed. Wake up America: a warning to the nation about sleep problems: report of the National Commission for the study of sleep disorders: key issues and a formal report. Moscow: Nauka; 1997. Russian (Романов А.И., ред. Проснись, Америка: предупреждение нации о проблемах сна: доклад Национальной Комиссии по исследованию расстройств сна. Москва: Наука; 1997)
3. Wayne A. M. Problems of somnology and sleep medicine. Actual problems of somnology: abstracts of reports of Russian conference (Moscow, 19-20 November 1998). Moscow; 1998: 4-11. Russian (Вейн А.М. Проблемы сомнологии и медицины сна. Актуальные проблемы сомнологии: тезисы до-кладов Всероссийской конференции (Москва 19-20 ноября 1998 г.). Москва; 1998: 4-11).
4. Cappuccio FP, Miller МА. Are Short Bad Sleep Nights a Hindrance to a Healthy Heart? Commentary on Hoevenaar-Blom et al. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN Study. Sleep 2011;34:1487-92.
5. Zavalko I. M., Кovalzon V. M. How did the science of sleep. Part I. Priroda 2014; 3: 53-60. Russian (За-валко И.М., Ковальзон В.М. Как возникла наука о сне. Часть I. Природа 2014; 3: 53-60).
6. Rechtschaffen A, Bergmann BM. Sleep deprivation in the rat: an update of the 1989 paper. Sleep 2002;25:18-24.
7. Kojima M, Wakai K, Kawamura T, et al. Sleep patterns and total mortality: a 12-year follow- up study in Japan. J Epidemiol 2000;10:87-93.
8. Tamakoshi A, Ohno Y. Self-reported sleep duration as a predictor of all-cause mortality: results from the JACC study, Japan. Sleep 2004;27(1):51-4.
9. Kripke DF, Garfinkel L, Wingard DL, et al. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002;59:131-6.
10. Hublin C, Partinen M, Koskenvuo M, Kaprio J. Sleep and mortality: a population-based 22-year follow-up study. Sleep 2007;30:1245-53.
11. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: metaanalysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665.
12. Gottlieb DJ, Redline S, Nieto FJ, et al. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep 2006;29(8):1009-14.
13. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 2006;47(5):833-9.
14. Van den Berg JF, Tulen JH, Neven AK, et al. Sleep duration and hypertension are not associated in the elderly. Hypertension 2007;50(3):585-9.
15. Wong LS, van der Harst P, de Boer RA, et al. Aging, telomeres and heart failure. Heart Fail Rev 2010;15(5):479-86.
16. Laugsand LE, Strand LB, Platou C, et al. Insomnia and the risk of incident heart failure: a population study. Eur Heart J 2013;5:1-12.
17. Hoevenaar-Blom MP, Spijkerman AMW, Kromhout D, et al. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN Study. Sleep 2011;34(11):1487-92.
18. Cappuccio FP, Cooper D, D'Elia L, et al. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J 2011;32(12):1484-92.
19. Ikehara S, Iso H, Date C, et al. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep 2009;32(3):259-301.
20. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 2006;47:833-9.
21. Cappuccio FP, Stranges S, Kandala NB, et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension. The Whitehall II Study. Hypertension 2007;50:694-701.
22. Cappuccio FP, Miller MA. Are short bad sleep nights a hindrance to a healthy heart? Sleep 2011;34(11):1457-8.
23. Ferrie JE, Shipley MJ, Cappuccio FP, et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II Cohort. Sleep 2007;30: 659-66.
24. Magee CA, Iverson DC, Caputi P. Factors associated with short and long sleep. Preventive Medicine 2009;49:461-7.
25. Brostrom A, Johansson P. Sleep disturbances in patients with chronic heart failure and their holistic consequences-what different care actions can be implemented? Eur J Cardiovasc Nurs 2005;4: 183-97.
26. Speidelhalder K, Scholtes C, Riemann D. The association between insomnia and cardiovascular diseases. Nat Sci Sleep 2010;2:71-8.
27. Drapkina O.M., Shepel R.N. Modern views on the role of telomeres and telomerase in the pathogenesis of hypertension. Arterial'naya Gipertenziya 2013; 19(4): 290-8. Russian (Драпкина О.М., Шепель Р.Н. Современные представления о роли теломер и теломеразы в патогенезе гипертонической болезни. Артериальная Гипертензия 2013; 19(4): 290-8).
28. Drapkina O.M., Shepel R.N. Telomeres and telomerase complex. The main clinical manifestation of genetic malfunctioning. Kardiovaskulyarnaya Terapiya i Profilaktika 2015; 14(1): 70-7. Russian (Драп-кина О.М., Шепель Р.Н. Теломеры и теломеразный комплекс. Основные клинические проявления генетического сбоя. Кардиоваскулярная Терапия и Профилактика 2015, 14(1): 70-7).
29. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2010;33:414-20.
30. Cappuccio FP, Taggart FM, Kandala NB, et al. Meta-analysis of short sleep duration and obesity in children, adolescents and adults. Sleep 2008;31:619-26.
31. Willeit P, Willeit J, Mayr A, et al. Telomere length and risk of incident cancer and cancer mortality. JAMA 2010;304:69-75.
32. Drapkina O.M., Shepel R.N. Telomeres and chronic heart failure. Kardiologiia 2014; 54(4): 60-7. Russian (Драпкина О.М., Шепель Р.Н. Теломеры и хроническая сердечная недостаточность. Кардиология 2014; 54(4): 60-7).
33. Ogami M, Ikura Y, Ohsawa M, et al. Telomere shortening in human coronary artery diseases. Arterioscler Tromb Vasc Diol 2004;24:546-50.
34. Jackowska M, Hamer M, Carvalho LA, et al. Short Sleep Duration Is Associated with Shorter Telomere Length in HealthyMen: Findings from the Whitehall II Cohort Study. PLoS ONE 2012;7(10):e47292.
35. Ha M, Park J. Shiftwork and metabolic risk factors of cardiovascular disease. J Occup Health 2005;7:89-95.
36. Esquirol Y, Bongard V, Mabile L, et al. Shift work and metabolic syndrome: respective impacts of job strain, physical activity, and dietary rhythms. Chronobiol Int 2009;26:544-59.
37. Pronk A, Ji BT, Shu XO, et al. Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol 2010;171:953-9.
38. Knutson KL. Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence. Best Pract Res Clin Endocrinol Metab 2010;24:731-43.
39. Kakizaki M, Kuriyama S, Sone T, et al. Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br J Cancer 2008; 99: 1502-5.
40. Liang G, Schernhammer E, Qi L, et al. Associations between Rotating Night Shifts, Sleep Duration, and Telomere Length in Women. PLoS ONE 2011;6(8):e23462.
41. Prather AA, Puterman E, Lin J, et al. Shorter leukocyte telomere length in midlife women with poor sleep quality. Journal of Aging Research 2011;1:1-6.
42. Bekaert S, De Meyer T, Rietzschel ER, et al. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell 2007;6:639-47.
43. Farzaneh-Far R, Lin J, Epel E, Lapham K, Blackburn E, et al. Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study. Plos One 2010;5:e8612.
44. Mullington JM, Haack M, Toth M, et al. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis 2009;51:294-302.
45. McEwen BS. Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load. Metabolism 2006;55:S20-S23.
46. Richter T, Von Zglinicki T. A continuous correlation between oxidative stress and telomere shortening in fibroblasts. Exp Gerontol 2007;42:1039-42.
47. Kawanishi S, Oikawa S. Mechanism of telomere shortening by oxidative stress. Ann NY Acad Sci 2004;1019:278-84.
48. Lusardi P, Mugellini A, Preti P, et al. Effects of a restricted sleep regimen on ambulatory blood pressure monitoring in normotensive subjects. Am J Hypertens 1996; 9: 503-5.
49. Kumari M, Badrick E, Ferrie J, et al. Self-reported sleep duration and sleep disturbance are independently associated with cortisol secretion in the Whitehall II study. J Clin Endocrinol Metab 2009;94: 4801-9.
50. Spath-Schwalbe E, Scholler T, Kern W, et al. Nocturnal adrenocorticotropin and cortisol secretion depends on sleep duration and decreases in association with spontaneous awakening in the morning. J Clin Endocrinol Metab 1992;75:1431-1435.
51. Choi J, Fauce SR, Effros RB. Reduced telomerase activity in human T- lymphocytes exposed to cortisol. Brain Behav Immun 2008;22:600-605.
Review
For citations:
Drapkina O.M., Shepel' R.N. SLEEP DURATION: MODERN VIEW OF THE PROBLEM FROM THE STANDPOINT OF A CARDIOLOGIST. Rational Pharmacotherapy in Cardiology. 2015;11(4):413-419. (In Russ.) https://doi.org/10.20996/1819-6446-2015-11-4-413-419
Views:
761
Email this article 